Literature DB >> 28867612

Achieving a Graded Immune Response: BTK Adopts a Range of Active/Inactive Conformations Dictated by Multiple Interdomain Contacts.

Raji E Joseph1, Thomas E Wales2, D Bruce Fulton1, John R Engen2, Amy H Andreotti3.   

Abstract

Capturing the functionally relevant forms of dynamic, multidomain proteins is extremely challenging. Bruton's tyrosine kinase (BTK), a kinase essential for B and mast cell function, has stubbornly resisted crystallization in its full-length form. Here, nuclear magnetic resonance and hydrogen-deuterium exchange mass spectrometry show that BTK adopts a closed conformation in dynamic equilibrium with open, active conformations. BTK lacks the phosphotyrosine regulatory tail of the SRC kinases, yet nevertheless achieves a phosphotyrosine-independent C-terminal latch. The unique proline-rich region is an internal "on" switch pushing the autoinhibited kinase toward its active state. Newly identified autoinhibitory contacts in the BTK pleckstrin homology domain are sensitive to phospholipid binding, which induces large-scale allosteric changes. The multiplicity of these regulatory contacts suggests a clear mechanism for gradual or "analog" kinase activation as opposed to a binary "on/off" switch. The findings illustrate how previously modeled information for recalcitrant full-length proteins can be expanded and validated with a convergent multidisciplinary experimental approach.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  BTK; TEC; autoinhibition; conformational equilibria; crystallization-resistant proteins; kinase regulation

Mesh:

Substances:

Year:  2017        PMID: 28867612      PMCID: PMC5629114          DOI: 10.1016/j.str.2017.07.014

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  36 in total

1.  BTKbase, mutation database for X-linked agammaglobulinemia (XLA)

Authors:  M Vihinen; B H Belohradsky; R N Haire; E Holinski-Feder; S P Kwan; I Lappalainen; H Lehväslaiho; T Lester; A Meindl; H D Ochs; J Ollila; I Vorechovsky; M Weiss; C I Smith
Journal:  Nucleic Acids Res       Date:  1997-01-01       Impact factor: 16.971

2.  Crystal structure of the Src family tyrosine kinase Hck.

Authors:  F Sicheri; I Moarefi; J Kuriyan
Journal:  Nature       Date:  1997-02-13       Impact factor: 49.962

3.  Three-dimensional structure of the tyrosine kinase c-Src.

Authors:  W Xu; S C Harrison; M J Eck
Journal:  Nature       Date:  1997-02-13       Impact factor: 49.962

4.  Structure of the carboxyl-terminal Src kinase, Csk.

Authors:  Akira Ogawa; Yoshiharu Takayama; Hiroaki Sakai; Khoon Tee Chong; Satoru Takeuchi; Atsushi Nakagawa; Shigeyuki Nada; Masato Okada; Tomitake Tsukihara
Journal:  J Biol Chem       Date:  2002-03-07       Impact factor: 5.157

5.  A sharp T-cell antigen receptor signaling threshold for T-cell proliferation.

Authors:  Byron B Au-Yeung; Julie Zikherman; James L Mueller; Judith F Ashouri; Mehrdad Matloubian; Debra A Cheng; Yiling Chen; Kevan M Shokat; Arthur Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-18       Impact factor: 11.205

6.  Identification of an allosteric signaling network within Tec family kinases.

Authors:  Raji E Joseph; Qian Xie; Amy H Andreotti
Journal:  J Mol Biol       Date:  2010-09-06       Impact factor: 5.469

Review 7.  The Btk subfamily of cytoplasmic tyrosine kinases: structure, regulation and function.

Authors:  D J Rawlings; O N Witte
Journal:  Semin Immunol       Date:  1995-08       Impact factor: 11.130

8.  Structural basis for the autoinhibition of c-Abl tyrosine kinase.

Authors:  Bhushan Nagar; Oliver Hantschel; Matthew A Young; Klaus Scheffzek; Darren Veach; William Bornmann; Bayard Clarkson; Giulio Superti-Furga; John Kuriyan
Journal:  Cell       Date:  2003-03-21       Impact factor: 41.582

9.  A novel oncogenic BTK isoform is overexpressed in colon cancers and required for RAS-mediated transformation.

Authors:  E Grassilli; F Pisano; A Cialdella; S Bonomo; C Missaglia; M G Cerrito; L Masiero; L Ianzano; F Giordano; V Cicirelli; R Narloch; F D'Amato; B Noli; G L Ferri; B E Leone; G Stanta; S Bonin; K Helin; R Giovannoni; M Lavitrano
Journal:  Oncogene       Date:  2016-01-25       Impact factor: 9.867

Review 10.  From identification of the BTK kinase to effective management of leukemia.

Authors:  C I E Smith
Journal:  Oncogene       Date:  2016-09-26       Impact factor: 9.867

View more
  16 in total

Review 1.  Polyphosphoinositide-Binding Domains: Insights from Peripheral Membrane and Lipid-Transfer Proteins.

Authors:  Joshua G Pemberton; Tamas Balla
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

Review 2.  Dynamic regulatory features of the protein tyrosine kinases.

Authors:  Neha Amatya; David Yin-Wei Lin; Amy H Andreotti
Journal:  Biochem Soc Trans       Date:  2019-08-08       Impact factor: 5.407

3.  A Combined Approach Reveals a Regulatory Mechanism Coupling Src's Kinase Activity, Localization, and Phosphotransferase-Independent Functions.

Authors:  Ethan Ahler; Ames C Register; Sujata Chakraborty; Linglan Fang; Emily M Dieter; Katherine A Sitko; Rama Subba Rao Vidadala; Bridget M Trevillian; Martin Golkowski; Hannah Gelman; Jason J Stephany; Alan F Rubin; Ethan A Merritt; Douglas M Fowler; Dustin J Maly
Journal:  Mol Cell       Date:  2019-04-04       Impact factor: 17.970

Review 4.  Novel roles of phosphoinositides in signaling, lipid transport, and disease.

Authors:  Gerald R V Hammond; John E Burke
Journal:  Curr Opin Cell Biol       Date:  2020-01-20       Impact factor: 8.382

5.  The Conformational State of the BTK Substrate PLCγ Contributes to Ibrutinib Resistance.

Authors:  Raji E Joseph; Jacques Lowe; D Bruce Fulton; John R Engen; Thomas E Wales; Amy H Andreotti
Journal:  J Mol Biol       Date:  2021-12-23       Impact factor: 5.469

Review 6.  Bruton's Tyrosine Kinase, a Component of B Cell Signaling Pathways, Has Multiple Roles in the Pathogenesis of Lupus.

Authors:  Anne B Satterthwaite
Journal:  Front Immunol       Date:  2018-01-22       Impact factor: 7.561

7.  Btk SH2-kinase interface is critical for allosteric kinase activation and its targeting inhibits B-cell neoplasms.

Authors:  Daniel P Duarte; Allan J Lamontanara; Giuseppina La Sala; Sukyo Jeong; Yoo-Kyoung Sohn; Alejandro Panjkovich; Sandrine Georgeon; Tim Kükenshöner; Maria J Marcaida; Florence Pojer; Marco De Vivo; Dmitri Svergun; Hak-Sung Kim; Matteo Dal Peraro; Oliver Hantschel
Journal:  Nat Commun       Date:  2020-05-08       Impact factor: 14.919

Review 8.  Identifying Novel Actionable Targets in Colon Cancer.

Authors:  Maria Grazia Cerrito; Emanuela Grassilli
Journal:  Biomedicines       Date:  2021-05-20

Review 9.  Reining in BTK: Interdomain Interactions and Their Importance in the Regulatory Control of BTK.

Authors:  Lauren E Kueffer; Raji E Joseph; Amy H Andreotti
Journal:  Front Cell Dev Biol       Date:  2021-06-23

Review 10.  The Src module: an ancient scaffold in the evolution of cytoplasmic tyrosine kinases.

Authors:  Neel H Shah; Jeanine F Amacher; Laura M Nocka; John Kuriyan
Journal:  Crit Rev Biochem Mol Biol       Date:  2018-09-05       Impact factor: 8.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.